Tag: Oral device
Oventus reaches milestone
May 2, 2022HME News Staff
BRISBANE, Australia – Oventus Medical’s direct-to-consumer market model reached its first optimization milestone in the third quarter of its fiscal year 2022: It delivered growth in active leads with a reduction in advertising spend of 20% less than the previous quarter, the company has announced. Despite the March quarter being slow due to seasonality, Oventus says new leads increased 63% with 6,100 generated. “With the weakest of insurance seasonality period behind us, we...
Oventus gains momentum with DTC model
February 28, 2022HME News Staff
IRVINE, Calif. – Oventus Medical has reported interim financial results for the six months ended Dec. 31, 2021, including $554,000 in revenue. The company, which makes the O2Vent oral device to treat obstructive sleep apnea, also reported cash receipts totaling $497,000, up 20% compared to the same period in 2020. “We are very encouraged by the way the move to direct-to-consumer marketing has resulted in substantial growth of the prospective customer pipeline,” said John Cox, who...
Oventus and Aeroflow get first distribution agreement
May 26, 2020HME News Staff
BRISBANE, Australia - Oventus Medical announced May 25 that Aeroflow Healthcare has executed its first subcontract to provide patients of Regional Health Diagnostics with the O2Vent Optima oral treatment for obstructive sleep apnea.“We have been working with Aeroflow for 15 years as the primary CPAP provider for our OSA patients,” said Jeff Ragan, president and CEO of Regional Health Diagnostics, which operates 12 sleep labs across Tennessee, Georgia, Alabama, and North and South Carolina....
ProSomnus takes to social media
January 29, 2020HME News Staff
SAN FRANCISCO - ProSomnus Sleep Technologies has launched #ShareYourStory, a social media campaign designed to raise awareness that prescription intraoral devices are a comfortable, effective and recommended alternative to CPAP. “Few are aware that CPAP is no longer the only treatment option for people suffering from sleep breathing issues, such as OSA,” stated ProSomnus, which manufacturers such devices, in a press release. “Covered by most medical insurances and Medicare, the...
Oventus ready to hit US market with oral device
September 6, 2019HME News Staff
BRISBANE, Australia - Oventus Medical has received regulatory clearance from the U.S. Food and Drug Administration for its O2Vent Optima oral device to treat obstructive sleep apnea. “We are thrilled to have received FDA clearance, which enables us to sell the O2Vent Optima in the U.S.—a core market for Oventus, alongside Canada and Australia,” said CEO Dr. Chris Hart. “We look forward to officially launching our material agreements within U.S. sleep channels and working with...